Calcium channel blocker and Parkinson’s disease

For those outside university library firewalls, I’m linking to the Faculty of 1000 link. Here’s the direct link the the Nature article. The key point is that in a mouse model of Parkinson’s disease, the calcium channel blocker, isradapine, acts to protect pars compacta dopamine neurons. In my opinion this discovery may have real significance for patients.

Jim